Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;61(586):e205-14.
doi: 10.3399/bjgp11X572391.

Identifying suspected breast cancer: development and validation of a clinical prediction rule

Colin McCowan  1 , Peter T Donnan, John Dewar, Alastair Thompson, Tom Fahey
Affiliations

Identifying suspected breast cancer: development and validation of a clinical prediction rule

Colin McCowan et al. Br J Gen Pract. 2011 May.

Abstract

Background: An evidence-based approach is needed to identify women with breast symptoms who are most likely to have breast cancer so that timely and appropriate referral can take place.

Aim: To report the development and validation of a clinical prediction rule for the diagnosis of breast cancer.

Design and setting: Cohort study with two prospective groups of women: those presenting to a symptomatic breast clinic (derivation cohort) and a separate cohort presenting to 11 general practices (validation cohort) in Tayside, Scotland.

Method: Regression analysis was used to derive a clinical prediction rule from presenting symptoms, personal and family history, and clinical findings. Validation consisted of estimating the number of breast cancers predicted to occur compared with the actual number of observed breast cancers across deciles of risk.

Results: In the derivation cohort of 802 patients, 59 (7%) were diagnosed with breast cancer. Independent clinical predictors for breast cancer were: increasing age by year (adjusted odds ratio [AOR] 1.10, 95% confidence interval [CI] = 1.07 to 1.13); presence of a discrete lump (AOR 15.20, 95% CI = 4.88 to 47.34); breast thickening (AOR 7.64, 95% CI = 2.23 to 26.11); lymphadenopathy (AOR 3.63, 95% CI = 1.33 to 9.92); and lump ≥ 2 cm (AOR 5.41, 95% CI = 2.36 to 12.38). All eight patients with skin tethering had breast cancer. The regression model had good predictive power, identifying all five breast cancers in the validation cohort of 97 patients in the top two deciles of risk.

Conclusion: The clinical prediction rule discriminates between patients at high risk of breast cancer from those at low risk, and can be implemented as an evidence-based recommendation to enhance appropriate referral from general practice to a symptomatic breast clinic. Ongoing validation in further populations is required.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expected versus observed breast cancers by decile of predicted risk in the validation cohort.
See this image and copyright information in PMC

Comment in

References

    1. Veronesi U, Boyle P, Goldhirsch A, et al. Breast cancer. Lancet. 2005;365(9472):1727–1741. - PubMed
    1. Ebbs S, Sierakowski A. Non-urgent breast referrals subsequently diagnosed with cancer. Br J Gen Pract. 2004;54(503):465–466. - PMC - PubMed
    1. Nichols S, Waters WE, Wheeler MJ. Management of female breast disease by Southampton general practitioners. BMJ. 1980;281(6253):1450–1453. - PMC - PubMed
    1. Newton P, Hannay DR, Laver R. The presentation and management of female breast symptoms in general practice in Sheffield. Fam Pract. 1999;16(4):360–365. - PubMed
    1. Roberts MM, Elton RA, Robinson SE, French K. Consultations for breast disease in general practice and hospital referral patterns. Br J Surg. 1987;74(11):1020–1022. - PubMed

Publication types